Explore the honest values of Joint from the community and select yours
-
Revenues: US $ 13.3 million (56% decrease of 2Q 2024).
-
Net loss: US $ 989.6K (loss reduced by 73% of 2Q 2024).
-
US $ 0.065 loss per share (improved of US $ 0.24 loss in 2q 2024).
This technology could replace computers: discover that the 20 shares work to realize Kwantum Computing.
All figures shown in the graph above are for the 12 -month period (TTM)
The turnover was in line with estimates of the analysts. The profit per share (EPS) exceeded the estimates of analysts by 143%.
Looking ahead, sales will grow on average by 22% PA over the next 3 years, compared to a growth roor spelling of 6.0% for healthcare in the US.
Implementation of the American health care industry.
The shares of the company have fallen 1.7% compared to a week ago.
What about risks? Every company has them, and we have seen 1 warning sign for joint You should know.
Feedback on this article? Worried about the content? Contact us With us immediately. As an alternative e-mail editorial team (AT) Easlewallst.com.
This article by Simply Wall St is generally in nature. We comment based on historical data and analyst forecasts that only use an unbiased methodology and our articles are not intended as financial advice. It is not a recommendation to buy or sell shares and does not take your objectives or your financial situation into account. We strive to bring you in the long term -targeted analysis, powered by fundamental data. Note that our analysis may not take into account the latest price -sensitive company announcements or qualitative material. Simply Wall St has no position in the aforementioned stocks.
